These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 3444826)
1. [Nonmedicinal prevention of liver involvement caused by isoniazid and monoacetylhydrazine in rats]. Koriakin VA; Nikolaev VP; Sokolova GB; Ziia AV; Abramovich AG; Protopopova MM Probl Tuberk; 1987; (12):49-52. PubMed ID: 3444826 [No Abstract] [Full Text] [Related]
2. The role of oxygen free radicals in isoniazid-induced hepatotoxicity. Walubo A; Smith P; Folb PI Methods Find Exp Clin Pharmacol; 1998 Oct; 20(8):649-55. PubMed ID: 9922980 [TBL] [Abstract][Full Text] [Related]
3. Cimetidine inhibits the formation of the reactive, toxic metabolite of isoniazid in rats but not in man. Lauterburg BH; Todd EL; Smith CV; Mitchell JR Hepatology; 1985; 5(4):607-9. PubMed ID: 4018731 [TBL] [Abstract][Full Text] [Related]
4. Isoniazid and iproniazid: activation of metabolites to toxic intermediates in man and rat. Nelson SD; Mitchell JR; Timbrell JA; Snodgrass WR; Corcoran GB Science; 1976 Sep; 193(4256):901-3. PubMed ID: 7838 [TBL] [Abstract][Full Text] [Related]
7. The role of metabolism in the hepatotoxicity of isoniazid and iproniazid. Timbrell JA Drug Metab Rev; 1979; 10(1):125-47. PubMed ID: 393481 [No Abstract] [Full Text] [Related]
8. Studies on the role of acetylhydrazine in isoniazid hepatotoxicity. Timbrell JA Arch Toxicol Suppl; 1979; (2):1-8. PubMed ID: 288324 [TBL] [Abstract][Full Text] [Related]
9. The relation of isoniazid (INH) and allied compounds to carcinogenesis in some species of small laboratory animals: a review. Biancifiori C; Severi L Br J Cancer; 1966 Sep; 20(3):528-38. PubMed ID: 5332032 [No Abstract] [Full Text] [Related]
15. Contact dermatitis from hydrazine hydrochloride in soldering flux; cross sensitization to apresoline and isoniazid. FROST J; HJORTH N Acta Derm Venereol; 1959; 39():82-6. PubMed ID: 13825413 [No Abstract] [Full Text] [Related]
16. Screening for prevention of isoniazid-associated liver disease. Tizes R; Hayden CH; Perrin P JAMA; 1971 Dec; 218(11):1703. PubMed ID: 5171051 [No Abstract] [Full Text] [Related]
17. [Hepatotoxic effect of a combination of pyrazinamide with isoniazid and rifampicin]. Slivka IuI; Klimniuk EV; Tabachuk OE Probl Tuberk; 1989; (4):39-42. PubMed ID: 2734263 [TBL] [Abstract][Full Text] [Related]
18. [Light microscope changes in rat liver after prolonged administration of 1,2-dimethylhydrazine]. Pataki A; Klotzsche C Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):421-2. PubMed ID: 4253846 [No Abstract] [Full Text] [Related]
19. [Review of the current state of knowledge on prophylactic use of INH]. Chwalibóg B Pneumonol Pol; 1980 Aug; 48(8):553-61. PubMed ID: 6999466 [No Abstract] [Full Text] [Related]
20. Comparative carcinogenicity of N-isopropyl-alpha-(2-methylhydraziono)-p-toluamide. HCI (procarbazine hydrochloride), its degradation products, other hydrazines, and isonicotinic acid hydrazide. Kelly MG; O'Gara RW; Yancey ST; Gadekar K; Botkin C; Oliverio VT J Natl Cancer Inst; 1969 Feb; 42(2):337-44. PubMed ID: 5765465 [No Abstract] [Full Text] [Related] [Next] [New Search]